VAN WIJMEERSCH, Bart

Email Alert RSS Feed

Profile

Full Name
VAN WIJMEERSCH, Bart
Email
bart.vanwijmeersch@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 121-140 of 152 (Search time: 0.01 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
1212016Alemtuzumab provides durable improvements in clinical outcomes in treatment-naive patients with active relapsing-remitting multiple sclerosis over 6 years in the absence of continuous treatment (CARE-MS I).Coles, A. J.; Boyko, A. N.; Cohen, J. A.; De Seze, J.; Fox, E. J.; Havrdova, E.; Hartung, H. -P.; Inshasi, J. S.; McCombe, P.; Selmaj, K. W.; Vermersch, P.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Rodriguez, C. E.; Montalban, X.Journal ContributionM
1222016Brain atrophy by automated MRI reading in long-term natalizumab treated patients: Real world data suggests brain atrophy rates in range of healthy individualsHorakova, Dana; Uher, T.; Vaneckova, M.; Krasensky, J.; Seidl, Z.; van Pesch, V.; Lysandropoulos, A.; VAN WIJMEERSCH, Bart; Ribbens, A.; van Hecke, W.; Dong, Q.; Farkas, M.; Hyde, R.; Koendgen, H.Journal ContributionM
1232016Effects of an individual 12 weeks community located running program on physical capacity, walking, cognitive function, dual tasking and brain volumes and structures in persons with Multiple Sclerosis.FEYS, Peter; MOUMDJIAN, Lousin; Vanhalewyck, F.; WENS, Inez; OP 'T EIJNDE, Bert; VAN WIJMEERSCH, Bart; POPESCU, Veronica; Dufour, A.; Delva, S.; VAN ASCH, PaulJournal ContributionM
1242016Design of two phase III open-label trials evaluating ocrelizumab in patients with relapsing-remitting multiple sclerosis and suboptimal response to disease-modifying treatmentBermel, R.; Comi, G.; Eralinna, J. -P.; Leist, T. P.; Nicholas, R.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Bernasconi, C.; Buffels, R.; Csoboth, C.; Han, J.; Musch, B.; Vermersch, P.Journal ContributionM
1252016Durable improvement in clinical outcomes in treatmentnaive patients with relapsing-remitting multiple sclerosis who switched from SC IFNB-1a to alemtuzumab (care-MS I extension study 4-year follow-up)Oreja-Guevara, C.; Alroughani, R.; Brassat, D.; Boyko, A. N.; McCombe, P.; Steingo, B.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Rodriguez, C. E.; Vermersch, P.Journal ContributionM
1262016Effects of teriflunomide treatment on the CD4(+) T-cell receptor repertoire in patients with relapsing-remitting MSKlotz, Luisa; Lindner, Maren; Gross, Catherina C.; Eschborn, Melanie; Posevitz-Fejfar, Anita; Schulte-Mecklenbeck, Andreas; Meuth, S. G.; VAN WIJMEERSCH, Bart; Hupperts, Raymond; Maeurer, M.; Stangel, M.; Lang, M.; Tackenberg, B.; Lysandropoulos, A.; Decoo, D.; Eveslage, M.; Turner, Timothy J.; Jagerschmidt, A.; Bar-Or, Amit; Wiendl, HeinzJournal ContributionM
1272015Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression indexDE BOCK, Laura; FRAUSSEN, Judith; Villar, Luisa M.; Alvarez-Cermeno, Jose C.; VAN WIJMEERSCH, Bart; van Pesch, Vincent; STINISSEN, Piet; SOMERS, VeerleJournal ContributionA1
1282015Associations of Upper Limb Disability Measures on Different Levels of the International Classification of Functioning, Disability and Health in People With Multiple SclerosisLAMERS, Ilse; Cattaneo, Davide; Chen, Christine C.; Bertoni, Rita; VAN WIJMEERSCH, Bart; FEYS, PeterJournal ContributionA1
92015Optimizing therapy early in multiple sclerosis: An evidence-based viewZiemssen, Tjalf; De Stefano, Nicola; Sormani, Maria Pia; VAN WIJMEERSCH, Bart; Wiendl, Heinz; Kieseier, Bernd C.Journal ContributionA1
102015Characterizing the impact of teriflunomide on adaptive immune cell subsets, repertoire and function in patients with relapsing-remitting MS: TERI-DYNAMICWiendl, H.; Gross, C. C.; Lindner, M.; Eschborn, M.; Weisser, L.; Posevitz-Fejfar, A.; Schulte-Mecklenbeck, A.; VAN WIJMEERSCH, Bart; Hupperts, R.; Lunven, C.; Brette, S.; Turner, T. J.; Klotz, L.Journal ContributionM
112015B cells from MS patients induce autoreactive Th1 and Th17 responsesFRAUSSEN, Judith; CLAES, Nele; HELLINGS, Niels; VAN WIJMEERSCH, Bart; STINISSEN, Piet; Hupperts, R.; SOMERS, VeerleJournal ContributionM
122015Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosisJANSSENS, Kris; Van den Haute, C.; Baekelandt, Veerle; Lucas, S.; VAN HORSSEN, Jack; VAN WIJMEERSCH, Bart; STINISSEN, Piet; HELLINGS, Niels; HENDRIKS, Jerome; SLAETS, Leen; SOMERS, VeerleJournal ContributionA1
132015Overview of the management of relapsing-remitting multiple sclerosis and practical recommendationsGallo, P.; VAN WIJMEERSCH, BartJournal ContributionA1
142015IL-15 Amplifies the Pathogenic Properties of CD4+CD28- T Cells in Multiple SclerosisBROUX, Bieke; Mizee, Mark R.; VANHEUSDEN, Marjan; VAN DER POL, Susanne; VAN HORSSEN, Jack; VAN WIJMEERSCH, Bart; SOMERS, Veerle; DE VRIES, Helga E.; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
152014Taking a closer look at Spag16 in multiple sclerosisDE BOCK, Laura; SOMERS, Klaartje; FRAUSSEN, Judith; HENDRIKS, Jerome; VAN HORSSEN, Jack; ROUWETTE, Myrthe; HELLINGS, Niels; Villar, Luisa M.; Alvarez-Cermeno, Jose C.; Hupperts, Raymond; Jongen, Peter; Damoiseaux, Jan; Verbeek, Marcel M.; De Deyn, Peter P.; D'hooghe, Marie; VAN WIJMEERSCH, Bart; STINISSEN, Piet; SOMERS, VeerleJournal ContributionM
162014Leukemia inhibitory factor shifts the immune balance towards regulatory T cellsJANSSENS, Kris; Van den Haute, Chris; Baekelandt, Veerle; VAN HORSSEN, Jack; VAN WIJMEERSCH, Bart; STINISSEN, Piet; HENDRIKS, Jerome; SLAETS, Leen; HELLINGS, NielsJournal ContributionM
172014HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.PANNEMANS, Kim; BROUX, Bieke; Goris, An; Dubois, Bénédicte; BROEKMANS, Tom; VAN WIJMEERSCH, Bart; Geraghty, Daniel; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
182014Significant and meaningful improvement in treatment satisfaction with teriflunomide versus subcutaneous ifnb-1A in patients with relapsing ms results from tenereMaurer, M.; VAN WIJMEERSCH, Bart; de Seze, J.; Meca-Lallana, J.; Bozzi, S.; Vermersch, P.Journal ContributionM
1792014Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up StudyCLAES, Nele; DHAEZE, Tessa; FRAUSSEN, Judith; BROUX, Bieke; VAN WIJMEERSCH, Bart; STINISSEN, Piet; HELLINGS, Niels; SOMERS, Veerle; Hupperts, RaymondJournal ContributionA1
1802013Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominanceLAMERS, Ilse; Kerkhofs, Lore; RAATS, Joke; Kos, Daphne; VAN WIJMEERSCH, Bart; FEYS, PeterJournal ContributionA1
show all